HeartR Occluder Series

Advanced Occluder Systems for ASD, VSD, and PDA Closure Procedures

Lifetech Scientific developed the HeartR Series as an advanced family of transcatheter closure devices designed for the treatment of congenital structural heart defects. Developed for minimally invasive management of atrial septal defects (ASD), ventricular septal defects (VSD), and patent ductus arteriosus (PDA), the HeartR Series combines high biocompatibility, controlled deployment performance, and reliable implant stability within a modern interventional cardiology platform.

As minimally invasive structural heart interventions continue to expand, transcatheter occluder systems have become an increasingly important treatment option for congenital heart disease management. The HeartR Series was developed to support this modern interventional approach by offering dedicated device solutions for multiple defect anatomies and clinical requirements.

The HeartR ASD Occluder is specifically designed for percutaneous closure of secundum atrial septal defects. Its dual-disc nitinol mesh structure provides stable septal positioning while supporting controlled deployment during implantation. The low-profile delivery system facilitates smooth transcatheter navigation and contributes to effective use in both pediatric and adult patient populations.

HeartR VSD Occluder systems are designed for muscular and selected perimembranous VSD procedures. The flexible nitinol framework is engineered to conform to varying defect anatomies while supporting stable device positioning. The fully retrievable deployment mechanism provides additional procedural safety and operator control during implantation.

For patent ductus arteriosus treatment, the HeartR PDA Occluder systems are optimized for different PDA morphologies. The conical device design and controlled expansion mechanism help achieve secure ductal occlusion while maintaining procedural stability. Low-profile delivery architecture provides additional advantages in pediatric interventions.

The nitinol alloy used throughout the HeartR Series offers excellent flexibility and shape-memory characteristics, improving anatomical adaptability and implant conformability. Polyester patch integration further supports rapid endothelialization and effective defect closure performance.

Lifetech Scientific’s manufacturing philosophy focuses strongly on long-term biocompatibility and structural durability. Electropolishing technologies and optimized braid construction contribute to improved implant surface quality and long-term device performance.

The HeartR Series is also designed to support controlled deployment workflows. Operators can reposition or retrieve the device during implantation when necessary, enhancing procedural precision and overall intervention safety.

Compared with traditional surgical repair procedures, minimally invasive transcatheter closure approaches using HeartR devices offer important advantages including reduced procedural trauma, shorter hospital stays, and faster patient recovery. As a result, transcatheter closure technologies continue to gain wider adoption in modern structural heart therapy.

In clinical practice, the HeartR Series is recognized for reliable implant stability, controlled deployment performance, and broad anatomical adaptability across different patient populations. The systems are widely applicable in pediatric cardiology and structural heart intervention procedures.

In summary, the HeartR Series represents a modern family of transcatheter closure systems developed for ASD, VSD, and PDA treatment applications. Through advanced nitinol technology, controlled deployment architecture, and minimally invasive treatment philosophy, the HeartR Series provides reliable solutions for contemporary interventional cardiology procedures.